Advertisement
UK markets closed
  • FTSE 100

    7,995.58
    +71.78 (+0.91%)
     
  • FTSE 250

    19,721.24
    -65.63 (-0.33%)
     
  • AIM

    755.91
    -2.92 (-0.38%)
     
  • GBP/EUR

    1.1694
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2451
    -0.0104 (-0.83%)
     
  • Bitcoin GBP

    54,072.36
    -2,682.00 (-4.73%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,123.41
    -75.65 (-1.46%)
     
  • DOW

    37,983.24
    -475.84 (-1.24%)
     
  • CRUDE OIL

    85.45
    +0.43 (+0.51%)
     
  • GOLD FUTURES

    2,360.20
    -12.50 (-0.53%)
     
  • NIKKEI 225

    39,523.55
    +80.92 (+0.21%)
     
  • HANG SENG

    16,721.69
    -373.34 (-2.18%)
     
  • DAX

    17,930.32
    -24.16 (-0.13%)
     
  • CAC 40

    8,010.83
    -12.91 (-0.16%)
     

Patient Recruitment and Retention Services Global Market Report 2024

Company Logo
Company Logo

Global Patient Recruitment and Retention Services Market

Global Patient Recruitment and Retention Services Market
Global Patient Recruitment and Retention Services Market

Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Patient Recruitment and Retention Services Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.

The patient recruitment and retention services market size has grown strongly in recent years. It will grow from $3.78 billion in 2023 to $4.01 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The increase in the historical period can be ascribed to conventional recruitment techniques, the expansion of clinical trials and research activities, the heightened complexity of trial protocols, evolving regulatory demands, and the growing adoption of patient-centric approaches.



The patient recruitment and retention services market size is expected to see strong growth in the next few years. It will grow to $4.96 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The anticipated growth in the forecast period is linked to a heightened emphasis on diversity within clinical trials, the escalating outsourcing of patient recruitment services, the broadening scope of precision medicine trials, advancements in data analytics for recruitment purposes, and a growing emphasis on real-world evidence in trials. Key trends expected in the forecast period involve the integration of social media into patient recruitment efforts, the creation of patient engagement platforms, a rise in virtual and decentralized trial approaches, the implementation of predictive analytics in recruitment strategies, and the customization of patient-centric trial designs.

The expansion of clinical trials is a key driver for the growth of the patient recruitment and retention services market. Clinical trials, focused on investigating novel procedures and medications and their impact on health outcomes, necessitate the identification and enrollment of eligible participants. Patient recruitment and retention services play a crucial role in facilitating this process, supporting the overall development of clinical trials. The increasing number of clinical trials, as evidenced by data from the World Health Organization, such as the rise from 9,175 to 10,966 clinical trials in Southeast Asia from 2020 to 2021, and from 17,161 to 17,756 in Europe during the same period, underscores the growing demand for patient recruitment and retention services.

The significant factor contributing to market growth is the surge in funding for clinical research. Clinical research funding, involving financial support for scientific studies related to understanding, diagnosing, treating, or preventing medical conditions, plays a crucial role in advancing medical knowledge. The portion allocated to patient recruitment and retention services is utilized to enhance processes for identifying and retaining participants in clinical trials. Notably, data from the National Institutes of Health reveals an increase in support for new and renewed extramural grants in Fiscal Year 2022, reaching a total of 58,368, representing a 2.8% rise compared to the previous year. The success rate for new Research Project Grants (RPGs) also increased by 1.6 percentage points, from 19.1% in 2021 to 20.7% in 2022. This substantial funding growth underscores the positive impact on the patient recruitment and retention services market.

ADVERTISEMENT

Report Scope

Markets Covered:
1) By Patient Recruitment Steps: Pre-screening; Screening
2) By Trial Phases: Phases I; Phases II; Phases III; Phases IV
3) By Therapeutic Areas: Cardiovascular Diseases; Oncological Disorders; Infectious Diseases; Central Nervous System Disorders; Respiratory Disorders; Hematological Disorders; Other Disorders

Key Companies Mentioned: IQVIA Holdings Inc; ICON PLC; Veradigm Inc.; Medpace Holdings Inc.; Worldwide Clinical Trials Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Key Attributes:

Report Attribute

Details

No. of Pages

175

Forecast Period

2024 - 2028

Estimated Market Value (USD) in 2024

$4.01 Billion

Forecasted Market Value (USD) by 2028

$4.96 Billion

Compound Annual Growth Rate

5.4%

Regions Covered

Global


For more information about this report visit https://www.researchandmarkets.com/r/wdzlz3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900